Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al
J Clin Oncol
.
2015 Apr 1;33(10):1221-3.
doi: 10.1200/JCO.2014.59.9373.
Epub 2015 Feb 17.
Authors
Sally F Barrington
1
,
N George Mikhaeel
2
,
Lale Kostakoglu
3
,
Michel Meignan
4
,
Martin Hutchings
5
,
Stefan Müeller
6
,
Lawrence H Schwartz
7
,
Emanuele Zucca
8
,
Richard I Fisher
9
,
Judith Trotman
10
,
Otto S Hoekstra
11
,
Rodney J Hicks
12
,
Michael J O'Doherty
13
,
Roland Hustinx
14
,
Alberto Biggi
15
,
Franco Cavalli
8
,
T Andrew Lister
16
,
Bruce D Cheson
17
Affiliations
1
King's College London, London, United Kingdom sally.barrington@kcl.ac.uk.
2
Guy's and St Thomas' National Health Service Foundation Trust, London, United Kingdom.
3
Mount Sinai Medical Center, New York, NY.
4
Centre Universitaire Hospitalier Henri Mondor, Creteil, Paris, France.
5
Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
6
Universitätsklinikum Essen, Essen, Germany.
7
Columbia University Medical Center, New York, NY.
8
Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland.
9
Fox Chase Cancer Center, Philadelphia, PA.
10
Concord Hospital, and University of Sydney, Sydney, New South Wales, Australia.
11
VU University Medical Centre, Amsterdam, the Netherlands.
12
Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, Victoria, Australia.
13
King's College London, London, United Kingdom.
14
University of Liège, Liège, Belgium.
15
Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy.
16
St Bartholomew's Hospital London, London, United Kingdom.
17
Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC.
PMID:
25691678
DOI:
10.1200/JCO.2014.59.9373
No abstract available
Publication types
Letter
Comment
MeSH terms
Fluorodeoxyglucose F18*
Humans
Lymphoma / diagnostic imaging*
Lymphoma / therapy*
Positron-Emission Tomography*
Radiopharmaceuticals*
Tomography, X-Ray Computed*
Substances
Radiopharmaceuticals
Fluorodeoxyglucose F18